Tyrosine Kinase Inhibitors (TKIs) in Trastuzumab Emtansine (T-DM1) Resistant HER2-positive Metastatic Breast Cancer: A Real-world Study
Status: UNKNOWN
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Interventions: DRUG: TKIs
Sponsor: The First Affiliated Hospital with Nanjing Medical University